Sometimes, exceptions can be made based on special circumstances
The regulator said on Tuesday it had conducted further analyses of placebo-controlled clinical trials involving GLP-1 drugs, which did not show an increased risk of suicidal thoughts or behavior versus placebo, or of other psychiatric side effects such as anxiety, depression, irritability or psychosis
Co to jest GLP-1 i jak dziaa
Tazawa K, Shimojima Y, Okano T, Yazaki M, Takei Y, Shimojo H, Kobayashi K, Saheki T, Ikeda S
But this strategy could subject Hims to risk of enforcement by the FDA and legal action from Novo, which has already filed over 60 lawsuits against firms unlawfully marketing semaglutide products and vowed to keep pursuing legal action against other entities engaged in similar conduct. When asked about its customized compounding approach, Hims directed Hunterbrook to information on its website about personalized healthcare, including an October white paper on the topic and a blog post highlighting their customers results with personalized weight loss products, as well as the Hims shareholder letter from Q3 2024
